262 related articles for article (PubMed ID: 18843027)
1. Decreasing cervical cancer mortality in Mexico: effect of Papanicolaou coverage, birthrate, and the importance of diagnostic validity of cytology.
Lazcano-Ponce E; Palacio-Mejia LS; Allen-Leigh B; Yunes-Diaz E; Alonso P; Schiavon R; Hernandez-Avila M
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2808-17. PubMed ID: 18843027
[TBL] [Abstract][Full Text] [Related]
2. Effective cervical cytology screening programmes in middle-income countries: the Chilean experience.
Sepúlveda C; Prado R
Cancer Detect Prev; 2005; 29(5):405-11. PubMed ID: 16188399
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of cervical cancer screening program at a rural community of South Africa.
Hoque M; Hoque E; Kader SB
East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
[TBL] [Abstract][Full Text] [Related]
4. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
Nygård M; Daltveit AK; Thoresen SO; Nygård JF
BMC Health Serv Res; 2007 Jan; 7():10. PubMed ID: 17244348
[TBL] [Abstract][Full Text] [Related]
5. Organisation of cervical cytology screening in Croatia: past, present and future.
Pajtler M; Audy-Jurković S; Kardum-Skelin I; Mahovlić V; Mozetic-Vrdoljak D; Ovanin-Rakić A
Coll Antropol; 2007 Apr; 31 Suppl 2():47-54. PubMed ID: 17598505
[TBL] [Abstract][Full Text] [Related]
6. [Challenges to implement strategies for the primary and secondary prevention of cervical cancer in Mexico].
Lazcano-Ponce E; Allen B; Palacio-Mejía LS; Hernández-Avila M
Gac Med Mex; 2006; 142 Suppl 2():43-9. PubMed ID: 19031678
[TBL] [Abstract][Full Text] [Related]
7. Validity of self-reported Pap smear history in Norwegian women.
Klungsøyr O; Nygård M; Skare G; Eriksen T; Nygård JF
J Med Screen; 2009; 16(2):91-7. PubMed ID: 19564522
[TBL] [Abstract][Full Text] [Related]
8. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with non-use of Pap test. A population survey.
Hernández-Hernández DM; García-Elizondo MR; Ornelas-Bernál L; Hernández-Alemán F; González-Lira G; Martínez-García MC
Arch Med Res; 1998; 29(3):263-70. PubMed ID: 9775462
[TBL] [Abstract][Full Text] [Related]
10. Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan.
Sung HY; Kearney KA; Miller M; Kinney W; Sawaya GF; Hiatt RA
Cancer; 2000 May; 88(10):2283-9. PubMed ID: 10820350
[TBL] [Abstract][Full Text] [Related]
11. Cervical cancer screening among Latinas recently immigrated to the United States.
Fernández-Esquer ME; Cardenas-Turanzas M
Prev Med; 2004 May; 38(5):529-35. PubMed ID: 15066355
[TBL] [Abstract][Full Text] [Related]
12. Social inequality in Pap smear coverage: identifying under-users of cervical cancer screening in Argentina.
Arrossi S; Ramos S; Paolino M; Sankaranarayanan R
Reprod Health Matters; 2008 Nov; 16(32):50-8. PubMed ID: 19027622
[TBL] [Abstract][Full Text] [Related]
13. Decline in cervical cancer incidence and mortality in New South Wales in relation to control activities (Australia).
Taylor R; Morrell S; Mamoon H; Wain G; Ross J
Cancer Causes Control; 2006 Apr; 17(3):299-306. PubMed ID: 16489537
[TBL] [Abstract][Full Text] [Related]
14. Effect of organized screening on incidence and mortality of cervical cancer in Denmark.
Lynge E; Madsen M; Engholm G
Cancer Res; 1989 Apr; 49(8):2157-60. PubMed ID: 2702657
[TBL] [Abstract][Full Text] [Related]
15. [Updated cervical cancer screening; human papilloma virus and Papanicolaou tests].
Sasagawa T
Rinsho Byori; 2009 Sep; 57(9):905-12. PubMed ID: 19860220
[TBL] [Abstract][Full Text] [Related]
16. Cervical cytology in vulnerable pregnant women.
Loomis DM; Pastore PA; Rejman K; Gutierrez KL; Bethea B
J Am Acad Nurse Pract; 2009 May; 21(5):287-94. PubMed ID: 19432913
[TBL] [Abstract][Full Text] [Related]
17. Awareness of breast and cervical cancer risk factors and screening behaviours among nurses in rural region of Turkey.
Yaren A; Ozkilinc G; Guler A; Oztop I
Eur J Cancer Care (Engl); 2008 May; 17(3):278-84. PubMed ID: 18419631
[TBL] [Abstract][Full Text] [Related]
18. Current techniques in screening for cervical cancer in Spain: updated recommendations.
Puig-Tintoré LM; Torné A; Alonso I
Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S8-S10. PubMed ID: 18606440
[TBL] [Abstract][Full Text] [Related]
19. Educational level and cervical cancer screening programs in a Venezuelan urban area.
Núñez-Troconis J; Velásquez J; Mindiola R; Munroe D
Invest Clin; 2008 Sep; 49(3):331-9. PubMed ID: 18846774
[TBL] [Abstract][Full Text] [Related]
20. Sentinel Pap smears in 261 invasive cervical cancer patients in Italy.
Igidbashian S; Maggioni A; Casadio C; Boveri S; Cristoforoni P; Sideri M
Vaccine; 2009 May; 27 Suppl 1():A34-8. PubMed ID: 19480959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]